Abstract:The escalating menace of multidrug-resistant (MDR) pathogens necessitates a paradigm shift from conventional antibiotics to innovative alternatives. Antimicrobial peptides (AMPs) emerge as a compelling contender in this arena. Employing in silico methodologies, we can usher in a new era of AMP discovery, streamlining the identification process from vast candidate sequences, thereby optimizing laboratory screening expenditures. Here, we unveil cutting-edge machine learning (ML) models that are both predictive and interpretable, tailored for the identification of potent AMPs targeting World Health Organization's (WHO) high-priority pathogens. Furthermore, we have developed ML models that consider the hemolysis of human erythrocytes, emphasizing their therapeutic potential. Anchored in the nuanced physical-chemical attributes gleaned from the three-dimensional (3D) helical conformations of AMPs, our optimized models have demonstrated commendable performance-boasting an accuracy exceeding 75% when evaluated against both low-sequence-identified peptides and recently unveiled AMPs. As a testament to their efficacy, we deployed these models to prioritize peptide sequences stemming from PEM-2 and subsequently probed the bioactivity of our algorithm-predicted peptides vis-à-vis WHO's priority pathogens. Intriguingly, several of these new AMPs outperformed the native PEM-2 in their antimicrobial prowess, thereby underscoring the robustness of our modeling approach. To elucidate ML model outcomes, we probe via Shapley Additive exPlanations (SHAP) values, uncovering intricate mechanisms guiding diverse actions against bacteria. Our state-of-the-art predictive models expedite the design of new AMPs, offering a robust countermeasure to antibiotic resistance. Our prediction tool is available to the public at https://ai-meta.chem.ncu.edu.tw/amp-meta.

An ensemble deep learning model for predicting minimum inhibitory concentrations of antimicrobial peptides against pathogenic bacteria

A deep learning method for predicting the minimum inhibitory concentration of antimicrobial peptides against Escherichia coli using Multi-Branch-CNN and Attention

Integrating genomic and molecular data to predict antimicrobial minimum inhibitory concentration in Klebsiella pneumoniae

Ensemble Machine Learning and Predicted Properties Promote Antimicrobial Peptide Identification

dsAMP and dsAMPGAN: Deep Learning Networks for Antimicrobial Peptides Recognition and Generation

Deep Learning for Novel Antimicrobial Peptide Design

Deep learning regression model for antimicrobial peptide design

Discovery of AMPs from random peptides via deep learning-based model and biological activity validation

AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens

Deep learning improves antimicrobial peptide recognition

A Practical Approach for Predicting Antimicrobial Phenotype Resistance in Staphylococcus Aureus Through Machine Learning Analysis of Genome Data

Predicting Minimum Inhibitory Concentration of Antimicrobial Peptides by the Pseudo-Amino Acid Composition and Gaussian Kernel Regression.

Identification of antimicrobial peptides from the human gut microbiome using deep learning

deepAMPNet: a novel antimicrobial peptide predictor employing AlphaFold2 predicted structures and a bi-directional long short-term memory protein language model

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Accelerating Antimicrobial Peptide Discovery for WHO Priority Pathogens through Predictive and Interpretable Machine Learning Models

KT-AMP: Enhancing Antimicrobial Peptide Functions Prediction Through Knowledge Transfer on Protein Language Model

AMPpred-EL: An effective antimicrobial peptide prediction model based on ensemble learning

Antimicrobial Peptides Prediction Method Based on Sequence Multidimensional Feature Embedding

Exploring the repository of designed bifunctional antimicrobial peptides through deep learning

Comprehensive assessment of machine learning-based methods for predicting antimicrobial peptides